AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.06
Delayed Data
As of 3:59pm ET
 -0.11 / -5.07%
Today’s Change
1.76
Today|||52-Week Range
9.60
-8.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues377.0K613.0K265.0K941.0K
 
 
 
 
 
Cost of Goods Sold733.0K1.1M902.0K1.4M
 
 
 
 
 
Depreciation And Amortization142.0K140.0K328.0K406.0K
 
 
 
 
 
 
Operating ExpensesGross Income-498.0K-625.0K-965.0K-869.0K
 
 
 
 
 
General Expenses8.8M10.4M11.4M12.5M
 
 
 
 
 
Research And Development3.6M2.7M1.4M1.2M
 
 
 
 
 
Total Operating Expenses9.7M11.6M12.6M14.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.3M-11.0M-12.3M-13.4M
 
 
 
 
 
Extraordinary Credit0.0023.0K23.0K--
 
 
 
Extraordinary Charge-22.0K0.00---98.0K
 
 
 
Interest Expense On Debt3.4M2.1M2.0M500.0K
 
 
 
 
 
Other Expenses334.0K472.0K604.0K554.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.5M-12.6M-13.7M-12.4M
 
 
 
 
 
Income Taxes0.000.000.00-3.0K
 
 
Net Income-12.5M-12.6M-13.7M-12.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.0M70.6M78.8M78.9M
 
 
 
 
 
Shares To Calculate EPS Diluted60.0M70.6M78.8M78.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.18-$0.17-$0.16
 
 
 
 
 
EPS Diluted-$0.21-$0.18-$0.17-$0.16